The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects-Reference-Cited by-同舟云学术

The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects

Published:2006-02 Issue:2 Volume:61 Page:191-199
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Sidhu Jagdev,Job Sarah,Singh Sunita,Philipson Richard

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2005.02539.x/fullpdf

Reference21 articles.

1. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy

2. Interactions Between Antiepileptic Drugs and Hormonal Contraception

3. Pharmacokinetic Drug Interactions with Oral Contraceptives

4. Clinical Pharmacokinetics of Contraceptive Steroids

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis;Epilepsia;2024-08-10

2. Trends in Antiseizure Medication Initiation, Switch, or Termination in Patients With Newly Diagnosed Epilepsy;Neurology;2024-07-23

3. Preconception counselling in women with epilepsy;Practical Neurology;2024-06-27

4. Fertility treatment for people with epilepsy;Practical Neurology;2024-02-26

5. Lamotrigine efficacy, safety, and tolerability for women of childbearing age with bipolar I disorder: Meta-analysis from four randomized, placebo-controlled maintenance studies;European Neuropsychopharmacology;2024-01